SAB Biotherapeutics Inc. (SABS)

NASDAQ: SABS · IEX Real-Time Price · USD
1.98
0.04 (2.06%)
May 27, 2022 4:00 PM EDT - Market closed

Ratios and Metrics (Annual)

Millions USD. Fiscal year is Jan - Dec.
YearCurrent2021
Market Capitalization
85340
Enterprise Value
69307
PE Ratio
--19.80
PS Ratio
-5.58
PB Ratio
2.068.81
P/OCF Ratio
-90.34
EV/Sales Ratio
-5.51
Debt / Equity Ratio
0.160.17
Debt / EBITDA Ratio
--0.44
Debt / FCF Ratio
--0.94
Current Ratio
1.981.96
Asset Turnover
-0.90
Return on Equity (ROE)
--44.20%
Return on Assets (ROA)
--25.20%
Return on Capital (ROIC)
--53.60%
Earnings Yield
--5.05%
FCF Yield
--2.12%
Buyback Yield / Dilution
--1.21%
Total Shareholder Return
--1.21%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).